Psyence Biomedical Ltd (NASDAQ:PBM) does about 2.31M shares in volume on a normal day but saw 1573088 shares change hands in the recent trading day. The company now has a market cap of 2.60M USD. Its current market price is $2.38, marking a decrease of -25.16% compared to the previous close of $3.18. The 52 week high reached by this stock is $945.15 whilst the lowest price level in 52 weeks is $1.51.
Psyence Biomedical Ltd (PBM) has a 20-day trading average at $2.54 and the current price is -99.75% off the 52-week high compared with 57.62% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.58 and its 200-day simple moving average is $35.66. If we look at the stock’s price movements over the week, volatility stands at 88.25%, which decreases to 40.83% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 41.36 to suggest the stock is neutral.
The current price level is -6.17%, -48.06%, and -93.33% away from its SMA20, SMA50, and SMA200 respectively, with the PBM price moving above the 50-day SMA on current market day. Psyence Biomedical Ltd (PBM) stock is up 28.65% over the week and -32.48% over the past month. Its price is -99.66% year-to-date and -99.73% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
Outstanding shares total 0.72M with insiders holding 11.14% of the shares and institutional holders owning 37.09% of the company’s common stock. The company has a return on equity of 1.27%. The beta has a value of -0.56.
